Millennials aren't the defining factor in Bank of America's mobile banking strength, which grew by 11 percent in the second quarter to 25.3 million active users, Chairman and CEO Brian Moynihan told CNBC on Monday.
"Our mobile capabilities and core mobile banking go far beyond the millennials," Moynihan told "Mad Money" host Jim Cramer in an exclusive interview after earnings.
"I got asked a question on the earnings call today, ��Is this millennials?��" the CEO said. "Well, there��s 35 million digital users. There aren��t enough millennials to do that. And so it spreads across all age cohorts, even guys as old as us, Jim."
Bank of America reported fiscal second-quarter earnings before Monday's opening bell. The country's second-largest lender saw profit climb 33 percent to $6.8 billion, trouncing Wall Street estimates of $5.92 billion.
Top 10 High Tech Stocks To Buy Right Now: Pingtan Marine Enterprise Ltd.(PME)
Advisors' Opinion:- [By Stephan Byrd]
Pingtan Marine Enterprise (NASDAQ:PME) CEO Xinrong Zhuo purchased 50,000 shares of Pingtan Marine Enterprise stock in a transaction on Thursday, May 17th. The shares were acquired at an average price of $3.66 per share, with a total value of $183,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
- [By Stephan Byrd]
Pingtan Marine Enterprise Ltd (NASDAQ:PME) CEO Xinrong Zhuo purchased 50,000 shares of the company’s stock in a transaction on Friday, May 25th. The shares were purchased at an average price of $3.33 per share, for a total transaction of $166,500.00. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website.
Top 10 High Tech Stocks To Buy Right Now: Ecolab Inc.(ECL)
Advisors' Opinion:- [By ]
3. Ecolab (NYSE: ECL)
This water, hygiene, and energy services company is being heavily bought by Bill Gates. Mr. Gates has purchased around a million shares across several transactions in the last 30 days. His purchase price was between $134.00 and $137.00 per share. - [By Logan Wallace]
Argus Investors Counsel Inc. bought a new position in Ecolab Inc. (NYSE:ECL) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,829 shares of the basic materials company’s stock, valued at approximately $257,000.
- [By ]
In the Lightning Round, Cramer was bullish on Goldman Sachs (GS) , Berkshire Hathaway (BRK.B) , Ecolab (ECL) , PTC (PTC) , Arista Networks (ANET) , U.S. Concrete (USCR) and Masco (MAS) .
- [By ]
Ecolab (ECL) : "That's a terrific situation that I want you to buy more of if it comes down."
PTC (PTC) : "Not my cup of tea but I understand it's in the sweet spot of tech."
- [By Neha Chamaria]
Using the above method, I believe the following five stocks are some of the best Dividend Aristocrats to consider today.
Dividend Aristocrat Payout Ratio (Last 12 Months) 5-Year Dividend CAGR*� 10-Year Dividend CAGR* Ecolab�(NYSE:ECL) 30.2% 12.9% 12.3% W.W. Grainger�(NYSE:GWW) 45.7% 10.6% 14.2% Cintas Corporation�(NASDAQ:CTAS) 23.7% 19.8% 13.1% Roper Technologies�(NYSE:ROP) 14.6% 20.4% 18.5% A. O. Smith�(NYSE:AOS) 33.6% 25.5% (2.2%)*Compound annual growth rate. Data source: S&P Global Market Intelligence. Table by author.
Top 10 High Tech Stocks To Buy Right Now: Intelsat S.A.(I)
Advisors' Opinion:- [By Rich Smith]
Another day, another 10%-plus move for Intelsat (NYSE:I)�stock.
It's Thursday, and Intelsat is moving steadily higher in afternoon trading, tipping the scales up 16.1% as of 12:12 p.m. EDT. The question is "why?"
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Intelsat (I)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Dorsey Wright & Associates purchased a new position in Intelsat SA (NYSE:I) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 735,371 shares of the technology company’s stock, valued at approximately $12,196,000. Intelsat accounts for 1.8% of Dorsey Wright & Associates’ portfolio, making the stock its 10th biggest holding. Dorsey Wright & Associates owned about 0.54% of Intelsat at the end of the most recent reporting period.
Top 10 High Tech Stocks To Buy Right Now: Progressive Corporation (PGR)
Advisors' Opinion:- [By Joseph Griffin]
Trexquant Investment LP bought a new stake in shares of Progressive Co. (NYSE:PGR) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 60,054 shares of the insurance provider’s stock, valued at approximately $3,659,000.
- [By Logan Wallace]
OppenheimerFunds Inc. lessened its holdings in shares of Progressive Corp (NYSE:PGR) by 0.5% in the first quarter, HoldingsChannel reports. The firm owned 5,359,477 shares of the insurance provider’s stock after selling 24,573 shares during the period. OppenheimerFunds Inc.’s holdings in Progressive were worth $326,553,000 at the end of the most recent quarter.
- [By Max Byerly]
Get a free copy of the Zacks research report on Progressive (PGR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Garrett Baldwin]
Let's talk the top news in the marijuana industry today… including four stocks that could surge up to 1,000% during this election year.�Here's what you need to know…
The Top Stock Market Stories for Tuesday Goldman Sachs Group Inc. (NYSE: GS) is leading a busy day of earnings reports on Tuesday. Shares are off 0.4% after the firm despite reporting a 40% year-over-year jump in profits and stronger-than-expected revenue. The firm reported earnings per share (EPS) of $5.98 on top of $9.40 billion in revenue. The Wall Street giant was expected to report EPS of $4.67 on top of $8.71 billion in revenue. The investment bank's first six months of 2018 were its strongest in nine years. The stock slipped after the company announced that president David Solomon will be replacing CEO Lloyd Blankfein when he steps down from his role. Blankfein has been CEO for 12 years. It's fair to say that�Amazon.com Inc. (Nasdaq: AMZN) went to the dogs on Monday. The company has extended its Prime Day promotion through 3 a.m. on Wednesday. The announcement came after the firm suffered significant outages during the start of the event on Monday afternoon. Rather than get access to deals, many customers were met with pictures of dogs, the firm's standard error page. Finally, pay close attention to events on Capitol Hill on Tuesday. The U.S. House Judiciary Committee will question leaders of Alphabet Inc. (Nasdaq: GOOGL), Twitter Inc. (NYSE: TWTR), and Facebook Inc. (Nasdaq: FB) about how they store and filter user content. Last year, the Senate and House of Representatives slammed the companies for their roles in and responses to Russia's interference in the 2016 election. Three Stocks to Watch Today: CSX, NFLX, KKR CSX Corp.�(Nasdaq: CSX) will help lead today's earnings calendar. Wall Street expects that the company will report EPS of $0.86 on top of $2.98 billion in revenue. Shares of Netflix Inc. (Nasdaq: NFLX) slipped after the firm's user-growth estimates and quart
Top 10 High Tech Stocks To Buy Right Now: Medical Marijuana, Inc. (MJNA)
Advisors' Opinion:- [By ]
Cronos was the first cannabis company to trade on NASDAQ, but the first American cannabis company to do it was Medical Marijuana Inc. (MJNA) . Developing legal cannabidiol (CBD) products made from hemp, Medical Marijuana Inc. had a major increase in sales from 2016 to 2017 and has begun looking into an expansion into international markets. Like with Aurora, these expenses have meant that it's not making much of a profit. With encouraging signs and warning signs each abounding, it comes down to whether you think this could be worth the risk.
- [By Sean Williams]
If I were to choose two marijuana stocks right off the bat that I'd rather watch from the sidelines and never buy, it'd be medical cannabis company Medical Marijuana Inc. (NASDAQOTH:MJNA) and cannabinoid-based drug developer AXIM Biotechnologies (NASDAQOTH:AXIM). The reason they're listed together is because Medical Marijuana Inc. owns 22.67 million shares of AXIM, which is about 40% of its outstanding share count. Their futures really are tied together.
- [By Javier Hasse]
Medical Marijuana Inc (OTC: MJNA) announced Q1 2018 as its largest sales revenue quarter in company history with a year-over-year gross revenue increase of 191 percent. Revenue exceeded $10.5 million. The company also announced its subsidiary Kannaway has partnered with Christian Okoye, former all-time rushing leader for the Kansas City Chiefs, to speak out on why the NFL should consider allowing its players to take cannabidiol (CBD). He’s stopped taking all pain medications and is now only taking CBD.
Top 10 High Tech Stocks To Buy Right Now: Duluth Holdings Inc.(DLTH)
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Duluth (DLTH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Express (NYSE: EXPR) and Duluth (NASDAQ:DLTH) are both small-cap retail/wholesale companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Duluth (DLTH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 High Tech Stocks To Buy Right Now: CF Industries Holdings, Inc.(CF)
Advisors' Opinion:- [By Stephan Byrd]
CF Industries (NYSE:CF) released its quarterly earnings results on Wednesday. The basic materials company reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.21, Briefing.com reports. The company had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.21 billion. CF Industries had a negative return on equity of 0.11% and a net margin of 10.96%. CF Industries’s revenue was up 15.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.10 earnings per share.
- [By Max Byerly]
Neuburgh Advisers LLC cut its stake in CF Industries (NYSE:CF) by 21.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,200 shares of the basic materials company’s stock after selling 2,464 shares during the quarter. Neuburgh Advisers LLC’s holdings in CF Industries were worth $347,000 at the end of the most recent quarter.
- [By Chris Lange]
The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was CF Industries Holdings, Inc. (NYSE: CF) which fell about 3% to $43.04. The stock��s 52-week range is $27.27 to $46.20. Volume was about 2.6 million compared to the daily average volume of 2.6 million.
Top 10 High Tech Stocks To Buy Right Now: Ligand Pharmaceuticals Incorporated(LGND)
Advisors' Opinion:- [By Logan Wallace]
Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
New York State Common Retirement Fund raised its stake in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) by 30.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,216 shares of the biotechnology company’s stock after purchasing an additional 13,219 shares during the period. New York State Common Retirement Fund owned 0.27% of Ligand Pharmaceuticals worth $9,285,000 at the end of the most recent quarter.
- [By Todd Campbell, Keith Speights, and Brian Feroldi]
Investing in biotech stocks can be risky because clinical trial failures can lead to eye-popping drops in share prices. Nevertheless, the potential to benefit from revolutionary new medicines can make owning biotech stocks in a diversified portfolio smart. If you're hunting for new biotech stocks to buy, these three Motley Fool investors think you should consider�Ligand Pharmaceuticals (NASDAQ:LGND), Viking Therapeutics (NASDAQ:VKTX), and Amarin Corporation (NASDAQ:AMRN). Each of these companies has catalysts that could make now a good time to pick up shares.
- [By Logan Wallace]
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has been assigned a consensus rating of “Buy” from the nine analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $159.00.
- [By Logan Wallace]
These are some of the news stories that may have effected Accern Sentiment’s scoring:
Get Ligand Pharmaceuticals alerts: Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.
Top 10 High Tech Stocks To Buy Right Now: America First Tax Exempt Investors L.P.(ATAX)
Advisors' Opinion:- [By Shane Hupp]
Shares of America First Tax Exempt Investors, L.P. (NASDAQ:ATAX) hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $6.47 and last traded at $6.43, with a volume of 54800 shares changing hands. The stock had previously closed at $6.43.
- [By Shane Hupp]
Get a free copy of the Zacks research report on America First Multifamily Investors (ATAX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on America First Multifamily Investors (ATAX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 High Tech Stocks To Buy Right Now: Kaman Corporation(KAMN)
Advisors' Opinion:- [By Shane Hupp]
Kaman Aircraft (NYSE:KAMN) hit a new 52-week high and low on Wednesday . The stock traded as low as $67.95 and last traded at $68.00, with a volume of 2807 shares traded. The stock had previously closed at $67.07.
No comments:
Post a Comment